Troup S - Search Results

1

Potential role of estrogen receptor alpha (ERalpha) phosphorylated at Serine118 in human breast cancer in vivo.

Murphy LC, Weitsman GE, Skliris GP, Teh EM, Li L, Peng B, Davie JR, Ung K, Niu YL, Troup S, Tomes L, Watson PH. Murphy LC, et al. Among authors: troup s. J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):139-46. doi: 10.1016/j.jsbmb.2006.09.021. Epub 2006 Nov 7. J Steroid Biochem Mol Biol. 2006. PMID: 17092701 Review.

2

Immunohistochemical validation of multiple phospho-specific epitopes for estrogen receptor alpha (ERalpha) in tissue microarrays of ERalpha positive human breast carcinomas.

Skliris GP, Rowan BG, Al-Dhaheri M, Williams C, Troup S, Begic S, Parisien M, Watson PH, Murphy LC. Skliris GP, et al. Among authors: troup s. Breast Cancer Res Treat. 2009 Dec;118(3):443-53. doi: 10.1007/s10549-008-0267-z. Epub 2008 Dec 23. Breast Cancer Res Treat. 2009. PMID: 19104930 Free PMC article.

3

The relevance of phosphorylated forms of estrogen receptor in human breast cancer in vivo.

Murphy LC, Skliris GP, Rowan BG, Al-Dhaheri M, Williams C, Penner C, Troup S, Begic S, Parisien M, Watson PH. Murphy LC, et al. Among authors: troup s. J Steroid Biochem Mol Biol. 2009 Mar;114(1-2):90-5. doi: 10.1016/j.jsbmb.2009.01.017. Epub 2009 Feb 6. J Steroid Biochem Mol Biol. 2009. PMID: 19429437 Review.

4

Necrosis and hypoxia in invasive breast carcinoma.

Tomes L, Emberley E, Niu Y, Troup S, Pastorek J, Strange K, Harris A, Watson PH. Tomes L, et al. Among authors: troup s. Breast Cancer Res Treat. 2003 Sep;81(1):61-9. doi: 10.1023/A:1025476722493. Breast Cancer Res Treat. 2003. PMID: 14531498

5

The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer.

Emberley ED, Niu Y, Curtis L, Troup S, Mandal SK, Myers JN, Gibson SB, Murphy LC, Watson PH. Emberley ED, et al. Among authors: troup s. Cancer Res. 2005 Jul 1;65(13):5696-702. doi: 10.1158/0008-5472.CAN-04-3927. Cancer Res. 2005. PMID: 15994944

6

Mammaglobin, a potential marker of breast cancer nodal metastasis.

Leygue E, Snell L, Dotzlaw H, Hole K, Troup S, Hiller-Hitchcock T, Murphy LC, Watson PH. Leygue E, et al. Among authors: troup s. J Pathol. 1999 Sep;189(1):28-33. doi: 10.1002/(SICI)1096-9896(199909)189:1<28::AID-PATH389>3.0.CO;2-H. J Pathol. 1999. PMID: 10451484

7

Expression of a repressor of estrogen receptor activity in human breast tumors: relationship to some known prognostic markers.

Simon SL, Parkes A, Leygue E, Dotzlaw H, Snell L, Troup S, Adeyinka A, Watson PH, Murphy LC. Simon SL, et al. Among authors: troup s. Cancer Res. 2000 Jun 1;60(11):2796-9. Cancer Res. 2000. PMID: 10850416

8

Lumican and decorin are differentially expressed in human breast carcinoma.

Leygue E, Snell L, Dotzlaw H, Troup S, Hiller-Hitchcock T, Murphy LC, Roughley PJ, Watson PH. Leygue E, et al. Among authors: troup s. J Pathol. 2000 Nov;192(3):313-20. doi: 10.1002/1096-9896(200011)192:3<313::AID-PATH694>3.0.CO;2-B. J Pathol. 2000. PMID: 11054714

9

Altered expression of estrogen receptor coregulators during human breast tumorigenesis.

Murphy LC, Simon SL, Parkes A, Leygue E, Dotzlaw H, Snell L, Troup S, Adeyinka A, Watson PH. Murphy LC, et al. Among authors: troup s. Cancer Res. 2000 Nov 15;60(22):6266-71. Cancer Res. 2000. PMID: 11103781

10

Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer.

Troup S, Njue C, Kliewer EV, Parisien M, Roskelley C, Chakravarti S, Roughley PJ, Murphy LC, Watson PH. Troup S, et al. Clin Cancer Res. 2003 Jan;9(1):207-14. Clin Cancer Res. 2003. PMID: 12538471

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

73 results

Search Page